(Q45939354)

18 December 2017

title

Effect of the MDR1 C3435T variant and P-glycoprotein induction on dicloxacillin pharmacokinetics. (English)

1 reference

18 December 2017

1 reference

1 reference

Wendy S Putnam

1

1 reference

18 December 2017

Jonathan M Woo

series ordinal

2

1 reference

18 December 2017

Yong Huang

series ordinal

3

1 reference

18 December 2017

Leslie Z Benet

series ordinal

4

1 reference

18 December 2017

publication date

1 April 2005

1 reference

18 December 2017

The Journal of Clinical Pharmacology

published in

1 reference

18 December 2017

volume

45

1 reference

18 December 2017

issue

4

1 reference

18 December 2017

page(s)

411-421

1 reference

18 December 2017

Expression of a multidrug-resistance gene in human tumors and tissues

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0091270004273492

Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004273492

Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004273492

Biochemical, cellular, and pharmacological aspects of the multidrug transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004273492

The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004273492

Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004273492

Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004273492

Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P-glycoprotein: implications for drug delivery and activity in cancer chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004273492

Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004273492

Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004273492

Identification of functionally variant MDR1 alleles among European Americans and African Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004273492

MDR1 gene polymorphisms and disposition of the P-glycoprotein substrate fexofenadine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004273492

A discordance of the cytochrome P450 2C19 genotype and phenotype in patients with advanced cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004273492

Abnormal expression of a 170-kilodalton P-glycoprotein encoded by MDR1 gene, a metabolically active efflux pump, in CD4+ and CD8+ T cells from patients with human immunodeficiency virus type 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004273492

Can the enhanced renal clearance of antibiotics in cystic fibrosis patients be explained by P-glycoprotein transport?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004273492

Active metabolites of isoxazolylpencillins in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004273492

Role of human MDR1 gene polymorphism in bioavailability and interaction of digoxin, a substrate of P-glycoprotein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004273492

The MDR1 C3435T polymorphism: effects on P-glycoprotein expression/function and clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004273492

Digoxin pharmacokinetics and MDR1 genetic polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004273492

MDR1 genotypes do not influence the absorption of a single oral dose of 1 mg digoxin in healthy white males

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004273492

Genetic polymorphisms in MDR1 and CYP3A4 genes in Asians and the influence of MDR1 haplotypes on cyclosporin disposition in heart transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004273492

Tacrolimus pharmacogenetics: polymorphisms associated with expression of cytochrome p4503A5 and P-glycoprotein correlate with dose requirement

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004273492

C3435T polymorphism in the MDR1 gene affects the enterocyte expression level of CYP3A4 rather than Pgp in recipients of living-donor liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004273492

No effect of MDR1 C3435T variant on loperamide disposition and central nervous system effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004273492

Differential recognition of beta -lactam antibiotics by intestinal and renal peptide transporters, PEPT 1 and PEPT 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004273492

The Effect of CYP3A5 and MDR1 Polymorphic Expression on Cyclosporine Oral Disposition in Renal Transplant Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004273492

21 January 2018

Identifiers

DOI

10.1177/0091270004273492

1 reference

18 December 2017

PubMed ID

15778422

1 reference

18 December 2017